unknown

Legal and executive headquarters are in Galway, Ireland, while operational headquarters are in Minneapolis, Minnesota, U.S.  All Ireland companies → — Founded 1949
Healthcare Conglomerate Medical Device / Hardware
Gastroenterology
Clinical Decision Support & Reference Gastroenterology AI
Public (listed on NYSE: MDT)

About unknown

Medtronic is a global leader in healthcare technology, dedicated to alleviating pain, restoring health, and extending life. The company develops and manufactures a vast array of medical devices and therapies, ranging from pacemakers and insulin pumps to advanced robotic-assisted surgery systems and AI-driven diagnostic tools. Medtronic operates in more than 150 countries and employs over 90,000 people.

For physicians, Medtronic offers solutions across four main portfolios: Cardiovascular, Neuroscience, Medical Surgical, and Diabetes. The company is actively integrating AI and data analytics into its technologies to empower clinicians with individualized treatment plans and improve outcomes. Examples of AI applications include computer-aided detection systems for colonoscopies (GI Genius™) to identify polyps, advanced algorithms in pulse oximeters (Nellcor™) for reliable readings, and AI-powered systems (AiBLE™) to enhance accuracy and planning in robotic-assisted surgeries, particularly for delicate spine procedures. Medtronic also utilizes AI in cardiac care with AccuRhythm™ AI algorithms to filter false alerts and provide clear data for heart monitoring. The company is committed to the responsible and ethical use of AI in healthcare, guided by its AI Compass framework.

Focus Areas

Medtronic focuses on developing and manufacturing healthcare technologies and therapies for over 70 chronic diseases and conditions. Key focus areas include: Cardiovascular (cardiac rhythm management interventional cardiology cardiac surgery peripheral vascular health structural heart and aortic) Neuroscience (cranial and spinal technologies neuromodulation neurovascular pelvic health and gastric therapies ear nose and throat) Medical Surgical (surgical endoscopy acute care and monitoring) and Diabetes. The company is also heavily invested in leveraging artificial intelligence data analytics and robotic-assisted surgery across these areas to improve diagnostics treatment planning and surgical precision.

Business Intelligence

TechnologyCloud-based digital portal (GAiTEWAY™ platform for spine surgery), AI-enabled capabilities (Stealth AXiS surgical system), Open-source technology platform (SPICE for data-driven, community-based healthcare delivery), NVIDIA Holoscan and IGX (real-time AI computing software platform for medical devices), Touch Surgery™ Ecosystem (digital technologies for surgical workflow, video, simulations, case management)

What Physicians Need to Know

Cardiovascular
Medtronic offers a comprehensive portfolio for cardiovascular health, including cardiac rhythm management (pacemakers, ICDs, CRT devices, insertable cardiac monitors), interventional cardiology (catheters, stents), cardiac surgery, peripheral vascular health, structural heart, and aortic therapies. They have developed world-first technologies like wearable and implantable pacemakers and remote patient monitoring systems. Their AccuRhythmu2122 AI algorithms improve the accuracy of alerts from insertable cardiac monitors, particularly for atrial fibrillation and asystole. Medtronic recently acquired CathWorks to integrate AI-powered coronary technology.
Neuroscience
Medtronic's neuroscience focus includes cranial and spinal technologies, neuromodulation, neurovascular, pelvic health, gastric therapies, and ear, nose, and throat solutions. They are a leader in deep brain stimulation (DBS) for conditions like Parkinson's disease, offering the Perceptu2122 family of neurostimulators with BrainSenseu2122 technology. BrainSenseu2122 technology provides real-time insights into a patient's brain signals, allowing for personalized and adaptive DBS therapy. Medtronic is also integrating brain-computer interfaces with their surgical navigation systems, such as the StealthStation, through partnerships like the one with Precision Neuroscience.
Medical Surgical
This area encompasses surgical, endoscopy, acute care, and monitoring solutions. Medtronic offers innovative surgical robotics, including the Hugou2122 Robotic-Assisted Surgery (RAS) system, designed for precision and versatility in soft-tissue surgeries. Their Touch Surgeryu2122 Enterprise platform allows surgeons to access and analyze surgical footage, facilitating learning and improvement. The Signiau2122 stapling system utilizes Adaptive Firingu2122 and Adaptive Compressionu2122 technologies for consistent staple lines. Medtronic's GI Geniusu2122 intelligent endoscopy module uses AI to detect lesions during colonoscopies, improving early detection of colorectal cancer.
Diabetes
Medtronic provides integrated systems for diabetes management, including insulin pumps and continuous glucose monitoring (CGM). Key products include the MiniMedu2122 780G system, a closed-loop insulin pump that automates insulin delivery and correction boluses, and the InPenu2122 smart insulin pen for those on multiple daily injections. They also offer the CareLinku2122 Clinic therapy management software for healthcare professionals. Medtronic is actively developing AI-powered solutions like the Sugar.IQ app, which acts as a 'personal diabetes assistant' by recognizing patterns in diabetes data.
Artificial Intelligence & Data Analytics
Medtronic heavily leverages AI and data analytics across its focus areas to improve diagnostics, treatment planning, and surgical precision. They have a global hub for AI and robotics in surgery in London, focusing on developing AI and digital technologies. Examples include AI algorithms for cardiac monitoring (AccuRhythmu2122), AI-powered decision support for surgeons (AiBLEu2122 system), and intelligent endoscopy modules (GI Geniusu2122). AI is also used in surgical education and performance through the Touch Surgeryu2122 ecosystem.
Robotic-Assisted Surgery
Medtronic is a leader in robotic-assisted surgery with systems like the Hugou2122 RAS system, which aims to transform surgery through precision and technology. These systems are designed to provide unparalleled access and precision in complex spine, cranial, and minimally invasive soft-tissue surgeries. The company emphasizes modular and upgradeable systems, compatibility with existing instrumentation, and analytics to inform decision-making.
Physician Tip

Medtronic emphasizes strong collaboration with physicians in developing and advancing therapies, recognizing their vital role in clinical insights, technology development, and educating other healthcare professionals. They offer educational resources, training opportunities, and patient-reported outcomes (PRO) software services to support physicians in optimizing patient care. Medtronic also provides direct access to product and clinical experts through their Connect.MeSM Remote Sales team, offering specialist guidance and informative product support. The company is committed to ethical collaboration and transparency regarding physician compensation.

Medtronic's technology stack for platforms like SPICE utilizes modern web technologies such as React, HTML5, SCSS, TypeScript, and npm for the presentation layer, and PostgreSQL for robust data storage. They also leverage Fast Healthcare Interoperability Resources (FHIR) for seamless exchange of health data between different healthcare systems, supporting interoperability, scalability, and ease of implementation. Medtronic's systems are designed to integrate AI and data analytics to provide real-time insights and personalized care across various devices and platforms, such as the integration of BrainSenseu2122 technology with DBS systems and AI algorithms with cardiac monitors.

Products by unknown

No products listed for this company yet. Know of one? Suggest it →

What the Web Says

Medtronic receives mixed reviews, with a strong sense of purpose and good compensation often highlighted by employees. However, there are recurring concerns about management, job security due to frequent layoffs, and outdated technology in some product lines, particularly insulin pumps and continuous glucose monitors (CGMs). Customer service for medical devices also appears to be a significant pain point for patients.

Overall: Mixed

Strengths

  • Strong company mission and purpose
  • Good coworkers and collaborative environment
  • Solid compensation and benefits
  • Opportunities for growth (though sometimes slow)
  • Interesting work and products
  • Global presence and talent magnet

Limitations

  • Frequent layoffs and poor job security
  • Dysfunctional team dynamics and bad management
  • Outdated technology in some product lines (e.g., insulin pumps, CGMs)
  • Poor customer service for medical devices
  • Bureaucratic and slow decision-making
  • Billing issues and deceptive practices reported by some customers

Based on reviews from: Indeed.com, Comparably, Quora, Reddit, Trustpilot, Integrated Diabetes Services, MiniMed, Capterra, G2

Last updated: 2026-10-11

Videos

News, demos, and interviews about unknown.

Loading videos...

Videos load interactively. If none appear, search YouTube for unknown →

View all on YouTube

Press & Coverage

Medtronic Press Release
Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.
Medtronic announced the final exchange ratio for its offer to exchange Medtronic ordinary shares for shares of common stock of MiniMed Group, Inc.
2026-10
Medtronic Press Release
Medtronic Receives Category I CPTu00ae Code Approvals for Altavivau2122 and Symplicity Spyralu2122 Systems
Medtronic received Category I CPTu00ae code approvals for its Altavivau2122 and Symplicity Spyralu2122 Systems, reflecting growing clinical evidence and physician adoption for treating urge urinary incontinence and hypertension.
2026-10
Medtronic Press Release
Medtronic announces regulatory milestones for newest cardiac mapping and ablation software
Medtronic announced FDA clearance and CE Mark for its latest Afferau2122 Prism-2 Mapping Software and CE Mark for PulseSelect ProxBoxu2122 Adapter with Proximity Indicator software, expanding cardiac mapping capabilities.
2026-09
MassDevice
Medtronic unveils AI computing platform for surgical robotics
Medtronic unveiled Touch Surgery Aide, a new AI-native surgical computing platform for robotic surgery, enabling real-time AI use during procedures and expanding the Touch Surgery ecosystem.
2026-07
Medtronic Press Release
Medtronic Announces FDA Clearance for LigaSureu2122 RAS Maryland Instrument on the Hugou2122 RAS System
Medtronic announced FDA clearance for its LigaSureu2122 RAS Maryland instrument on the Hugou2122 RAS system, bringing trusted vessel-sealing technology to robotic-assisted surgery in the U.S.
2026-09
Investing News Network
Medtronic Study Reveals AI-Enabled Clinician Alerts Significantly Improve Evaluation and Valve Intervention For Patients With Heart Valve Disease
A Medtronic-sponsored study, the ALERT Trial, demonstrated that AI-enabled electronic clinician notifications significantly improve the timely evaluation and treatment of aortic stenosis and mitral regurgitation.
2026-05
Healthcare Dive
Medtronic starts to notify people affected by cyberattack
Medtronic began notifying individuals affected by a cyberattack, stating that there is currently no evidence of the accessed data being posted online.
2026-07
Morningstar
Medtronic Impact Report Highlights More Than 82 Million Patients Served Worldwide in Fiscal Year 2026
Medtronic released its fiscal year 2026 Impact Report, highlighting that the company served over 82 million patients globally, invested $2.9 billion in R&D, and achieved more than 315 product approvals.
2026-10

Frequently Asked Questions

Medtronic offers a broad portfolio of medical devices and therapies across several key areas, including Cardiovascular (e.g., pacemakers, stents, heart valves), Neuroscience (e.g., spinal implants, neurostimulators, neurovascular devices), Medical Surgical (e.g., surgical instruments, endoscopy systems, patient monitoring), and Diabetes (e.g., insulin pumps, continuous glucose monitoring systems). They also integrate AI, data analytics, and robotic-assisted surgery to enhance these offerings.
Medtronic is committed to rigorous compliance and patient safety. They adhere to global regulatory standards, including FDA regulations and CE marking requirements, throughout the entire product lifecycle, from design and manufacturing to post-market surveillance. The company also invests heavily in clinical trials and quality control processes to ensure the efficacy and safety of their products.
Medtronic's pricing structure varies depending on the specific device, therapy, and volume of purchase. They aim to provide competitive pricing while reflecting the advanced technology and clinical value of their products. For detailed pricing information and comparisons, it's best to contact a Medtronic sales representative directly to discuss specific needs and potential contracting options.
Medtronic offers comprehensive clinical and technical support for its products. This includes dedicated field representatives, clinical specialists for training and case support, technical support hotlines, and extensive educational resources. They also provide ongoing training and professional development programs for healthcare professionals to ensure optimal use of their technologies.
Yes, Medtronic actively engages in partnerships with healthcare providers, academic institutions, and research organizations. These collaborations often focus on advancing medical research, developing new therapies, improving patient outcomes, and optimizing healthcare delivery. They also partner to integrate their technologies into broader healthcare solutions.
Medtronic is a well-established global leader in medical technology with a strong financial foundation and a long-term vision focused on innovation and improving human health. They continuously invest in research and development, strategic acquisitions, and emerging technologies like AI and robotics to maintain their market leadership and ensure sustained growth and stability.
Medtronic is heavily invested in leveraging AI and data analytics across its portfolio to enhance diagnostics, personalize treatment planning, and improve surgical precision. This includes developing AI-powered algorithms for image analysis, predictive analytics for patient management, and data-driven insights to optimize device performance and clinical workflows.

Related Companies

OrthoAI is an innovative AI-powered platform designed to assist orthopedic surgeons in clinical decision-making, surgical planning, and patient care. It functions as a 24/7 surgical companion, providing evidence-based answers to complex clinical questions, surgical techniques, and theoretical queries. The platform leverages a meticulously curated database developed by expert orthopedic surgeons, integrates with PubMed for the […]

NuvoAir is a digital health company that provides a value-based specialty care platform focused on proactive, continuous virtual care for individuals with heart and lung conditions. The company aims to transform the diagnosis and management of chronic cardiopulmonary conditions by integrating advanced monitoring technology, data analytics, and evidence-based interventions delivered by a multidisciplinary team. NuvoAir’s […]

Infinite Biomedical Technologies, LLC (IBT) is a medical device company established in 1997 with roots at Johns Hopkins University. The company is dedicated to developing innovative solutions for individuals with upper limb loss and differences, aiming to transform laboratory research into practical medical devices. IBT focuses on advanced prosthetic control systems and related technologies to […]

The search results indicate that “Strain AI” is not a single, unified company serving physicians and healthcare providers in the traditional medical sense. Instead, the term “Strain AI” appears to be a general descriptor used by several distinct companies operating primarily in the cannabis industry, leveraging AI to recommend cannabis strains based on user preferences, […]

Samsung is a global technology leader that has significantly expanded its presence in the healthcare sector, leveraging its expertise in AI, imaging, and connected devices. The company aims to improve patient care and outcomes by providing advanced diagnostic solutions, personalized health insights, and integrated digital health platforms. Samsung’s healthcare initiatives focus on bridging the gap […]

Cardiologs, now part of Philips, is a medical technology company dedicated to transforming cardiac diagnostics through the application of medical-grade artificial intelligence (AI) and cloud technology. The company’s core offering is an AI-powered platform that analyzes electrocardiogram (ECG) recordings to detect various cardiac arrhythmias and other heart conditions. Developed in collaboration with leading cardiologists and […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.